Literature DB >> 17934085

Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra.

Loes M Kuijk, Anita M A P Govers, Joost Frenkel, Willem J D Hofhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17934085      PMCID： PMC2111630          DOI： 10.1136/ard.2007.071498

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

Authors:  Philip N Hawkins; Helen J Lachmann; Michael F McDermott
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

2.  Safety of extended treatment with anakinra in patients with rheumatoid arthritis.

Authors:  R M Fleischmann; J Tesser; M H Schiff; J Schechtman; G-R Burmester; R Bennett; D Modafferi; L Zhou; D Bell; B Appleton
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

3.  Anakinra for flares of pyogenic arthritis in PAPA syndrome.

Authors:  M P Dierselhuis; J Frenkel; N M Wulffraat; J J Boelens
Journal:  Rheumatology (Oxford)       Date:  2005-01-05       Impact factor: 7.580

4.  Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis.

Authors:  Serdar Daysal; Gulhan Akcil; Berna Goker; Seminur Haznedaroglu; Nil Ercan; Mehmet Akif Ozturk
Journal:  Arthritis Rheum       Date:  2005-02-15

5.  Familial Mediterranean fever successfully treated with etanercept.

Authors:  Adam Mor; Michael H Pillinger; Mitsumasa Kishimoto; Aryeh M Abeles; Avi Livneh
Journal:  J Clin Rheumatol       Date:  2007-02       Impact factor: 3.517

6.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

7.  Familial Mediterranean fever responds well to infliximab: single case experience.

Authors:  Salih Ozgocmen; Levent Ozçakar; Ozge Ardicoglu; Ercan Kocakoc; Arzu Kaya; Adem Kiris
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

8.  The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.

Authors:  Jae Jin Chae; Geryl Wood; Seth L Masters; Katharina Richard; Grace Park; Brian J Smith; Daniel L Kastner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

9.  Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.

Authors:  Hal M Hoffman; Sanna Rosengren; David L Boyle; Jae Y Cho; Jyothi Nayar; James L Mueller; Justin P Anderson; Alan A Wanderer; Gary S Firestein
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

10.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Authors:  Raphaela Goldbach-Mansky; Natalie J Dailey; Scott W Canna; Ana Gelabert; Janet Jones; Benjamin I Rubin; H Jeffrey Kim; Carmen Brewer; Christopher Zalewski; Edythe Wiggs; Suvimol Hill; Maria L Turner; Barbara I Karp; Ivona Aksentijevich; Frank Pucino; Scott R Penzak; Margje H Haverkamp; Leonard Stein; Barbara S Adams; Terry L Moore; Robert C Fuhlbrigge; Bracha Shaham; James N Jarvis; Kathleen O'Neil; Richard K Vehe; Laurie O Beitz; Gregory Gardner; William P Hannan; Robert W Warren; William Horn; Joe L Cole; Scott M Paul; Philip N Hawkins; Tuyet Hang Pham; Christopher Snyder; Robert A Wesley; Steven C Hoffmann; Steven M Holland; John A Butman; Daniel L Kastner
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245
  10 in total
  34 in total

Review 1.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors:  B Manger; M Gaubitz; H Michels
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 3.  Autoinflammation: translating mechanism to therapy.

Authors:  Taylor A Doherty; Susannah D Brydges; Hal M Hoffman
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

4.  Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

Authors:  Jae Jin Chae; Young-Hun Cho; Geun-Shik Lee; Jun Cheng; P Paul Liu; Lionel Feigenbaum; Stephen I Katz; Daniel L Kastner
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

Review 5.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

6.  Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.

Authors:  Nilüfer Alpay; Abdullah Sumnu; Yaşar Calışkan; Halil Yazıcı; Aydın Türkmen; Ahmet Gül
Journal:  Rheumatol Int       Date:  2010-04-13       Impact factor: 2.631

Review 7.  IL-1β biological treatment of familial Mediterranean fever.

Authors:  Alessandra Soriano; Elena Verecchia; Antonella Afeltra; Raffaele Landolfi; Raffaele Manna
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 8.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors:  Raphaela Goldbach-Mansky; Daniel L Kastner
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 9.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 10.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.